Google Search

Search

Already a Member ?

IV Fluids, I.V. solutions, Intravenous fluids, Normal Saline (NS, 0.9NaCl, or NSS), Lactated Ringers (LR, Ringers Lactate, or RL), Dextrose 5%, Normal Saline (Half Normal Saline, 0.45NaCl, .45NS), IV Fluids & Dialysis products - LVP/SVP Volume Parenteral

 

I V Fluids

Intravenous therapy (IV) is therapy that delivers fluids directly into a vein. The intravenous route of administration can be used both for injections, using a syringe at higher pressures; as well as for infusions, typically using only the pressure supplied by gravity. Intravenous infusions are commonly referred to as drips.

The intravenous route is the fastest way to deliver medications and fluid replacement throughout the body, because they are introduced directly into the circulation. Intravenous therapy may be used for fluid volume replacement, to correct electrolyte imbalances, to deliver medications, and for blood transfusions.

Infusion therapy as a basic toll of modern medical care enables the physician to restore and stabilize homeostasis states quickly and completely. In nursing homes and hospital where patients are suffering from acute dehydration or considerable debilitating conditions, the intra venous fluids are used as I.V. drips. The basic function of I.V. fluids is to replenish the body fluids. Although there are number of I.V. fluids, but generally three types of I.V. fluids are used in hospitals as I.V. drips. 1. Dextrose injection fluid. 2. Dextrose and sodium chloride injection fluid. 3. Sodium Chloride injection solution (Saline solution). Dextrose solution is used during postoperative period when sodium extraction of 10-15% are used as diuretic for increasing in urine flow. Saline solution is used when large amount of sodium has been lost by vomiting or by gastric or intestinal duodenal aspiration or through an alimentary fistula. Dextrose monohydrate is used as supplement to cow’s milk in part of feeding. Hypertonic dextrose solution (25-50%) is in medical treatment partly because they are believed to strengthen heart muscles. Hypertonic solutions are used in intravenous injection to relieve intractable pressure in-patient with hydrocephalus and meningitis. The drug industry has now achieved an impressive growth during the last four decades of planning and development. These I.V. fluids are the best alternative, which can yield sudden result in the health of a Patient by replenishing the body fluids.

Intravenous solutions have evolved with technologies and designs improving their overall functionalities. There are several combinations of packaged intravenous products that have come up in recent years. Manufacturers are introducing IV fluids and compounds that can be mixed with other liquid medicines and solutions for IV administration. The aforementioned factors will continue to drive the global intravenous (IV) solution market.  Some of the factors that are having positive impact on the growth of the intravenous (IV) solution market include increased prevalence of chronic disorders and growing popularity of IV led treatments and therapies intended towards curing cance.

Uses and Applications

There are main ranges of application of highly specialized intravenous infusion solutions:

• Treatment of discarded water and electrolyte metabolism, especially in severe cases.

• Therapy of acid base in balances.

• The volume substitution and volume replacement in surgery of accident victim suffering blood loss.

• Paratral nutrition for severally ill and post-operative patients.

Aqueous isotonic injection (5%) of dextrose is given as intravenous injections to increase the column of circulating blood in the shocks and hemorrhages and to counteract dehydration. When it is desired to replace excessive salt loss also glucose is injected along with sodium chloride. Intravenous fluids can also be used as a route of medication administration. If a doctor wants to delI.V.er a small amount of medication over an extended period of time, it can be dissolved in a bag of intravenous fluids and set on an infusion pump which delivers the medicated fluid directly into the blood.

They are also commonly used to assist with surgical recovery; people who receive fluids after surgery tend to experience better recovery than people who do not.

Global Intravenous Solutions Market Trends:

Over the past few years, the prevalence of hectic work schedules and unhealthy lifestyles has increased across the globe. The consequent decline in physical activity and proper nutrition has led to a rise in the incidences of chronic diseases, which in turn has boosted the demand for intravenous solutions. Besides, there has been significant growth in the production of IV fluids, particularly in developed countries. For instance, it was reported that due to the shortage of IV saline, the US Food and Drug Administration (FDA) and other market. The intravenous fluid bags market size will grow at a CAGR of 6% at an incremental growth of $ 667.51 MN during 2020-2024.

The increasing prevalence of chronic diseases such as the rise of cholera and growing acceptance of vitamin c intravenous for colorectal cancer are the major drivers propelling market growth. However, the presence of stringent government regulations, rising continuous demand for IV solutions in the US, and increasing vitamin C intravenous therapy prices constrain the growth of the market.

The rising number of surgeries, the need for a faster route of drug administration, growing preference for single-dose administration of vaccines and drugs, and an increase in local manufacturing is expected to drive the market for LVP. Parenteral route of administration helps provide an accurate dose of medication as the majority of the drug is directly absorbed in circulation, bypassing the gastrointestinal tract.

The drug serum level increases rapidly through parenteral administration. For instance, postoperative parenteral nutrition induces a substantial increase in serum leptin within six hours and helps reach a rise of more than four folds within 14 hours. Moreover, parenteral administration of ascorbate (Vitamin C) decreases the growth rate of murine hepatoma. However, oral administration of the same dosage does not exhibit similar anti-tumoral effects.

Advantages of BFS Technology:

Blow-fill-seal technology enables the manufacture of preservative-free single-unit doses. PreservatI.V.es are recognized as potentially harmful to the sensitive mucosae of the eyes, nose, and lungs, so this is an enormous benefit to sensitive patients. Another advantage of unit-doses is that they ensure that the patient takes the correct amount of product, especially when dealing with highly potent compounds, i.e. those therapeutically active at a low concentration.

Sterile unit-doses are portable and easy to use individually, excellent properties for today’s active lifestyles. Blow-fill-seal (BFS) single doses are an ideal solution for use in ophthalmology, respiratory diseases, rhinology, and antisepsis and wound care. Blow-fill-seal technology reduces personnel intervention making it a more robust method for the aseptic preparation of sterile pharmaceuticals. BFS is used for the filling of vials for parenteral preparations and infusions, eye drops, and inhalation products. Generally the plastic containers are made up of polyethylene and polypropylene. Polypropylene is more commonly used to form containers which are further sterilized by autoclaving as polypropylene has greater thermo stability.

Blow Fill and Seal technology is mainly used for pharmaceutical solutions. The examples of pharmaceutical solutions that can be packaged are injectable solutions, antibiotics, ophthalmological drops, suspensions, infusion solutions, solutions for dialysis, solutions for irrigation and solutions for hemofiltration. The basic concept of BFS is that a container is formed, filled, and sealed in a continuous process without human intervention, in a sterile enclosed area inside a machine. Thus this technology can be used to aseptically manufacture sterile pharmaceutical liquid dosage forms.

The process is multi-stepped: first, pharmaceutical-grade plastic resin is vertically heat extruded through a circular throat to form a hanging tube called the parison. This extruded tube is then enclosed within a two-part mould, and the tube is cut above the mould. The mould is transferred to the filling zone, or sterile filling space, where filling needles (mandrels) are lowered and used to inflate the plastic to form the container within the mould. Following the formation of the container, the mandrel is used to fill the container with liquid. Following filling the mandrels are retracted and a secondary top mould seals the container. All actions take place inside a sterile shrouded chamber inside the machine. The product is then discharged to a non-sterile area for labeling, packaging and distribution. The process begins with the Extrusion of plastic granules in the form of a hot hollow pipe of molten plastic called a parison.

The following step is the Blow molding of the container from the plastic granule. The parison is closed between the mould, and the container gets formed either by blowing sterile compressed air or by vacuum or by using vacuum as well as blowing. The container assumes the shape of the cavity in the mould. The container thus produced is open from the top and in its top part, the plastic is still hot and in molten state until the subsequent steps of filling and container sealing.

Features:

1. 100% film utilization: No waste edge between bags, reducing both material and energy consumption.

2. Special I.V. bag design: each bag saves 10mm film than others.

3. Reliable heating and welding system: Leakage rate less than 0.03%.

4. Quick changeover: 0.5-1 hour to switch from one size to another.

5. Stable transmission system: only needs 1 control system, 1 HMI and 1 operator.

6. Safe filling nozzle: No solution overflows, no particles generation.

7. Auto faulty rejection system detected by the machine.

8. Production line length is reduced by 1/3, both workshop and air conditioning and cleaning area are reduced by 1/3, greatly reducing the initial investment and future running cost.

9. Simple structure, more stable and reliable performance.

 

 

 

Reasons for buying our reports:

This report helps you to identify a profitable project for investing or diversifying into by throwing light to crucial areas like industry size, market potential of the product and reasons for investing in the product

This report provides vital information on the product like its characteristics and segmentation

This report helps you market and place the product correctly by identifying the target customer group of the product 

This report helps you understand the viability of the project by disclosing details like machinery required, project costs and snapshot of other project financials

The report provides a glimpse of government regulations applicable on the industry

The report provides forecasts of key parameters which helps to anticipate the industry performance and make sound business decisions.

 

Our Approach:

Our research reports broadly cover Indian markets, present analysis, outlook and forecast for a period of five years.

The market forecasts are developed on the basis of secondary research and are cross-validated through interactions with the industry players

We use reliable sources of information and databases. And information from such sources is processed by us and included in the report


 

 

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 5 of 5 | Total 48 projects in this category
« Previous   Page 1 2 3 4 5   »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

IV Fluids (BFS Technology)

Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids when they are sick, to keep their fluid volume stable. Another cause is blood loss, which causes problems both because people lose blood products, and because they experience a loss in fluid volume. Electrolyte levels in the blood can also become unstable as a result of rapid changes in fluid volume, in which case intravenous fluids can be used to restore the balance. Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenous administration. The global Intravenous (IV) solutions market was valued at USD 6.9 billion in 2015 and is projected to grow at a CAGR of 7.8% over the forecast period. The emergence of this market is attributed to the fast growing geriatric population and prevalence of malnutrition in the elderly and pediatric population. Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation. These fluids are sterile fluids which protects patients at the time of serious dehydration. There is various type of IV solutions available for use in the market. Many companies manufacture packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. This is attributed to the factors such as Growing acceptance of vitamin C intravenous for Colorectal Cancer and increasing prevalence of the chronic diseases. Europe is the second largest market which is growing at a CAGR of 8.12% from 2016-2022. Asia-Pacific region is the fastest growing market for IV Solutions, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022. Few Indian major players are as under Shree Krishna Keshav Laboratories Ltd. Pharmazell (India) Pvt. Ltd. Parenteral Surgicals Ltd. Kokad Pharmaceutical Laboratories Ltd. Ahlcon Parenterals (India) Ltd. Abaris Healthcare Pvt. Ltd. Axa Parenterals Ltd.
Plant capacity: IV Fluids (500 ml Size Pack): 146,748 Units / Day IV Fluids (100 ml Size Pack): 153,252 Units / DayPlant & machinery: Rs 4099 lakhs
Working capital: -T.C.I: Cost of Project : Rs 5808 lakhs
Return: 25.00%Break even: 41.00%
Add to Inquiry Add to Inquiry Basket

How to Start Pasta and Macaroni Manufacturing Business?

How to Start Pasta and Macaroni Manufacturing Business? Investment Opportunities in Food Processing Sector. Pasta is a type of food typically made from an unleavened dough of wheat flour mixed with water or eggs, and formed into sheets or other shapes, then cooked by boiling or baking. Rice flour, or legumes such as beans or lentils, are sometimes used in place of wheat flour to yield a different taste and texture, or as a gluten-free alternative Pastas are divided into two broad categories: dried (pasta secca) and fresh (pasta fresca). Most dried pasta is produced commercially via an extrusion process, although it can be produced at home. Fresh pasta is traditionally produced by hand, sometimes with the aid of simple machines. Related Projects: - Food Processing and Agriculture Based Projects Pasta is the Italian designation or name given to a type of starchy noodle or dumpling food or dish typically made from grain flour, commonly wheat, mixed into a paste or dough, usually with water or eggs, and formed or cut into sheets or other shapes. It is usually cooked by boiling, baking or frying. Rice flour, or legumes such as beans or lentils, are sometimes used in place of wheat flour to yield a different flavour and texture, or as a gluten-free alternative. Pasta is a staple food ingredient of Italian cuisine. Macaroni is dry pasta shaped like narrow tubes. Made with durum wheat, macaroni is commonly cut in short lengths; curved macaroni may be referred to as elbow macaroni. Some home machines can make macaroni shapes, but like most pasta, macaroni is usually made commercially by large-scale extrusion. The curved shape is created by different speeds of extrusion on opposite sides of the pasta tube as it comes out of the machine. Related Books: - Food Processing, Food Industry, Agriculture, Agro Processing Macaroni is a variety of pasta and is used to make various pasta recipes. macaroni can be substituted in many recipes which call for other types of pasta like penne, fusilli, rigatoni etc. Uses Pasta is generally served with some type of sauce; the sauce and the type of pasta are usually matched based on consistency and ease of eating. Northern Italian cooking uses less tomato sauce, garlic and herbs, and white sauce is more common. However Italian cuisine is best identified by individual regions. Pasta dishes with lighter use of tomato are found in Trentino-Alto Adige and Emilia Romagna. In Bologna, the meat-based Bolognese sauce incorporates a small amount of tomato concentrate and a green sauce called pesto originates from Genoa. In Central Italy, there are sauces such as tomato sauce, amatriciana, arrabbiata and the egg-based carbonara. Tomato sauces are also present in Southern Italian cuisine, where they originated. Market Outlook Pasta is a traditional Italian dish and represents one of the most accessible and healthy carbohydrate-rich foods. It is made from unleavened dough consisting of wheat durum flour and water or eggs. There is a large variety of pasta and it is usually available in different sizes and shapes. It can be added to soups; boiled and served with a sauce; served cold with other ingredients in a salad; and stuffed with meat, cheese or vegetables and then boiled and baked. The consumption of pasta has increased among the health-conscious consumers around the world as it is cholesterol-free and low in sodium. Related Videos: - Food Processing Originating from Italy, pasta is now considered a global cuisine. Typically made from unleavened dough of durum wheat flour blended with eggs or water, it is available in the market in various shapes. To entice consumers, small and large manufacturers are now experimenting with different ingredients ranging from chickpea flour and rice flour to tomato, spinach, carrot, or beet juices and different herbs and spices for enhanced flavor and color. The global pasta market was estimated at 13 (USD Billion) in 2019 and is projected to be valued at 16 (USD Billion) by 2025 at a CAGR of about 2.9% over 2019-2025. The global pasta market is being driven by a number of favourable factors. On account of hectic lifestyles, consumers are shifting towards easy-to-makefood products. Since pasta is a convenient and healthy product, the demand for pasta, particularly for products such as vermicelli, fusilli and macaroni, has been on a rise. However, the rising popularity of low-carbohydrate diets can pose a threat to the market growth. Related Project: - Pasta and Macaroni The pasta market in India reached a sales value of US$ 335.4 Million in 2018, exhibiting a CAGR of 17.1% during 2011-2018. Looking forward, the market value is projected to reach US$ 821.9 Million by 2024, registering a CAGR of 16% during 2019-2024. On account of increasing awareness about health benefits of pasta as it is made of semolina durum wheat and not from refined flour. Further, the health-conscious consumers are demanding food products with healthier ingredients, which has led to a rise in the demand for pasta made with whole-wheat and quinoa. Some of the other forces that have been proactive in maintaining the market growth are longer shelf-life and ease of preparation. Market Research: - Market Research Report Key Players:- Bambino Agro Inds. Ltd. Bambino Food Inds. Ltd. Capital Foods Pvt. Ltd. Fieldfresh Foods Pvt. Ltd. I T C Ltd. M T R Foods Pvt. Ltd. Nestle India Ltd. Savorit Ltd. Shree Foods Ltd. Venkatramana Food Specialities Ltd. Weikfield Foods Pvt. Ltd. Tags: - #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #industrialproject #entrepreneurindia #startupbusiness #startupbusinessideas #FoodProcessing #foodindustry #Pasta #PastaManufacturing #pastaproduction #pastaindustry #pastabusiness #pastaproject #Macaroni #MACARONIPRODUCTION #macaronibusiness #macaroniproject #Macaronifood #pastafood
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Liquid Glucose & Fructose from Broken Rice

Liquid glucose is a solution of glucose suspended in liquid and sold in jars or tubs. Many companies manufacture glucose in powdered form to which water can be added to make liquid glucose, to make transportation of this product easier. Liquid glucose is available from a variety of sources, depending on how one intends to use it. Medical suppliers sometimes carry it, as do some grocery stores, especially stores with a large baking section. This monosaccharide is produced through the processing of starches such as corn and wheat. Rice Fructose Syrup is very sweet with Fructose content ranging from 40-90%. As a substitute of sucrose, Rice Fructose syrup contains higher sweetness than sucrose and has wider applications. Commercially it is widely used in food, canned fruit, jam, dairy products, beverage, tobacco, cold drink, fruit juice, preserved fruit, wines, heath food, salad dressings, household seasonings and chemicals. High Fructose Rice Syrup can partially or totally replace sucrose in beverage production or food processing. Fructose is majorly used in the production of nutrition bars, soft moist cookies, pourable frozen juice concentrates and energy-reduced products. It is commercially available in syrup and crystalline forms. High fructose corn syrup, which is the major product segment in the market, is expected to experience reduced demand on account of growing concerns regarding obesity. Fructose syrups is the fastest growing product segment and expected to register a CAGR of 4.7% from 2017 to 2025 due to increased demand from the beverage manufacturing industry. The glucose syrup market is classified based on grade as food, Pharma, and others. The food-grade segment is anticipated to generate revenue of USD 1.4 billion by 2025. High demand for sweeteners in the confectionery grades and growth of the bakery industry are the key factors boosting the segment growth. Liquid Glucose is mainly used in Candy Confectionery and Sweet Making Pharmaceuticals, Flavoring etc. The demand in these regions is stable and drives the development of Liquid Glucose Market. Thus, due to demand it is best to invest in this project. Few Indian major players are as under Kasyap Sweetners Ltd. Laxmi Starch Ltd. Gujarat Ambuja Proteins Ltd. Gulshan Polyols Ltd. K G Gluco Biols Ltd. Kamala Sugar Mills Ltd.
Plant capacity: Liquid Glucose : 112 MT / Day Fructose : 80 MT / Day Broken Rice Protein (Bye Product) : 8 MT / DayPlant & machinery: Rs 3936 lakhs
Working capital: -T.C.I: Cost of Project : Rs 5941 lakhs
Return: 26.00%Break even: 45.00%
Add to Inquiry Add to Inquiry Basket

IV Fluids (BFS Technology)

Fluids are given when someone's body fluid volume falls. There are a number of things which can cause a drop in fluid volume. Vomiting and diarrhea are a classic example, which is why people are encouraged to drink fluids when they are sick, to keep their fluid volume stable. Another cause is blood loss, which causes problems both because people lose blood products, and because they experience a loss in fluid volume. Electrolyte levels in the blood can also become unstable as a result of rapid changes in fluid volume, in which case intravenous fluids can be used to restore the balance. Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenous administration. Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation. These fluids are sterile fluids which protects patients at the time of serious dehydration. There are various type of IV solutions available for use in the market. Many companies manufacture packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for Intravenous (IV) Solution is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Thus, due to demand it is best to invest in this project. Few Indian major players are as under Abaris Healthcare Pvt. Ltd. Axa Parenterals Ltd. Infutec Healthcare Ltd. Parenteral Surgicals Ltd Pharmazell (India) Pvt. Ltd. Shree Krishna Keshav Laboratories Ltd. Punjab Formulations Ltd.
Plant capacity: IV Fluids (500 ml Size Bottle) :100,000 Bottles / DayPlant & machinery: Rs 751 lakhs
Working capital: -T.C.I: Cost of Project : Rs 1277 lakhs
Return: 26.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

Production of Disposable IV Set

Production of Disposable IV Set. Manufacturing Business Plan for Startups in Infusion Set. Intravenous therapy (abbreviated as IV therapy) is a medical technique that delivers a liquid directly into a person's vein. The intravenous route of administration is commonly used for rehydration solutions or to provide nutrition in those who cannot consume food or water by mouth. It may also be used to administer medications or other medical therapy such as blood products or electrolytes to correct electrolyte imbalances. Related projects: - Surgical, Medical Plastics, Medical Disposables, Disposable Medical Products used in Hospitals Medical establishments use Intravenous (IV) sets to administer fluid therapy and to provide medicines and blood products such as platelets. This procedure is called infusion therapy. IV sets use a process called gravity infusion to conduct the above procedures. Common Features For gravity feed only 15 micron fluid filter in drip chamber Soft and kink resistant DEHP free PVC tubing ensures uniform flow rate Smooth roller clamp facilitates easy, safe control and djustment of fluid rates Standard tube length: 150 cms Tube dia: I Ø 3 mm & O Ø 4.1 mm Related Books: - Disposable Products (Medical, Surgical, Thermocol, Plastic, Paper, Domestic And General Products) Uses Hospitals Ambulatory Surgical Centers Specialized Clinics Skilled Nursing Facilities Long Term Care Centers Others Related Videos:- Disposable Products Market Outlook The increased patient base in different regions comprising patients affected with diabetes and chronic pain is anticipated to drive the growth of the global IV tubing sets and accessories market. Increasing prevalence of chronic disease cases such as cancer have resulted in the development and introduction of advanced IV tubing sets to be used in infusion therapy for efficient treatment methods. Over the last few years, an increase in the demand for branded and patented smart IV infusion pump systems and associated IV tubing sets has been registered from end users such as hospitals, ambulatory surgical centers, homecare settings and long term care centers in Europe as compared to Asia Pacific. Related project: - Production of IV Infusion Set (IV Set) Besides, growing import and export of infusion pumps, consumables and supplies in countries such as France, Netherlands, United Kingdom, Poland and Russia is anticipated to boost the growth of the global IV tubing sets market. The market in high income countries is also growing due to its frequent replacement in the majority of hospitals as a basic medical supply necessity, product innovation, and strong guidelines by regulatory agencies to limit ill impacts. By 2020, the U.S. infusion therapy device market size was valued at $2.9 billion, with over 230 million primary IV sets sold every year. Despite COVID19, the market size is expected to increase at a compound annual growth rate (CAGR) of 2.6% to reach $3.5 billion in 2026. Related Videos: - Business Ideas for Startups Infusion Therapy Market Insights The infusion therapy device market is a relatively stable and mature market. This means that future growth in the market is expected to be limited by only mild gains to unit sales. Infusion pumps and IV sets, two of the largest market segments, are saturated in terms of the installed base and unit sales. Since infusion therapy is a well-established practice, there is very little room for expansion. For other mature markets, one standard way of driving market growth is to offer premium-priced products with advanced features. However, this practice has achieved only limited success in the infusion therapy device market. Related Videos: - Small Business Ideas Market Taxonomy By Product Type • Primary IV Tubing Sets o Macro-Drip IV Sets o Micro-Drip IV Sets • Secondary IV Tubing Sets • Extension IV Tubing Sets • I.V. Infusion Set with Flow Regulator • Filtered IV Tubing Sets • Non-Vented IV Tubing Sets • Vented IV Tubing Sets • IV Tubing Accessories By Application • Peripheral Intravenous Catheter Insertion • Central Venous Catheter Placement • PICC Line Insertion By End User • Hospitals • Ambulatory Surgical Centers • Specialized Clinics • Skilled Nursing Facilities • Long Term Care Centers • Others Insight by Application On the basis of application, the global IV tubing sets and accessories market is categorized into peripheral intravenous catheter insertion, PICC line insertion, and central venous catheter placement. In 2019, the peripheral segment accounted for the largest market share and will remain dominate till 2027. The rising cases life-style borne cardiac ailments and increasing preference of consumers towards minimally invasive procedures are the prominent factors favoring the segment growth? Moreover, rising cases of home-based infusion therapies among geriatrics also increasing the demand of the concerned product. The central venous catheter segment is projected to have the fastest growth rate over the study period. The usage of catheter in the administration of drugs in the veins is the major factor boosting its growth. Projects: - Project Reports & Profiles Key Players:- Angi Plast Pvt. Ltd. Axiom Medisurg Ltd. Hemant Surgical Inds. Ltd La Medical Devices Ltd. Sangam Health Care Products Ltd. Smiths Medical India Pvt. Ltd. Books:- BOOKS & DATABASES Tags:- #infusionset #ivset #IVSetManufacturing #IVSetProduction #IVSetBusiness #IVSetBusinessIdeas #InfusionSetmanufacturing #InfusionSetInvestment #InfusionSetMarket #InfusionSetBusinessplan #IntravenousSetMarket #NewRelease #Startupbusinessideas #businessestostart #startupideas #businessstartupindia #StartupBusiness #projectconsultancy #businessconsulting #projectconsultant #InvestmentOpportunities #DetailedProjectReport #businessconsultant #BusinessPlan #feasibilityReport #NPCS #ManufacturingBusiness #ProductionBusiness #IVSetBusinessPlan
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Lucrative Business of IV Fluids (BFS Technology)

Intravenous fluids are fluids that are supplied intravenously, or directly through the circulatory system, to a patient. When a person's bodily fluid volume drops, they are given fluids. A drop in fluid volume can be caused by a variety of factors. Intravenous fluids are divided into two categories. Crystalloids, such as saline solutions, contain a solution of water-soluble molecules. • Electrolyte metabolism and treatment of waste water, especially in extreme cases. • Treatment for acid-base imbalances. • Volume substitution and replacement in the surgery of an accident victim who has lost blood. • Dextrose solution is utilized during the postoperative period when sodium extraction is reduced, and it is used for severally unwell and post-operative patients. The global intravenous solutions market is estimated to reach USD 18.9 billion by 2028, with a compound annual growth rate (CAGR) of 7.9% from 2021 to 2028. The market is likely to be driven by a rising incidence rate of chronic diseases such as cancer, an increase in the number of premature births, and a lack of I.V. solutions in the United States. Severe dehydration is one of the most common uses for intravenous (IV) fluids. In disorders like diarrhoea, severe dehydration occurs as a result of the body's fluids being depleted. The continuing COVID-19 epidemic is likely to boost the market's performance. Due to the significant intake of patients infected with severe acute respiratory syndrome coronavirus 2, intensive care units (ICU) around the world are either at maximum capacity or overcrowded (SARS-CoV-2).
Plant capacity: IV Fluids (500 ml Size Bottle) 100,000.0 Bottles per dayPlant & machinery: 751 Lakhs
Working capital: -T.C.I: Cost of Project: 1277 Lakhs
Return: 26.48%Break even: 54.19%
Add to Inquiry Add to Inquiry Basket

IV Fluids (BFS Technology)

Intravenous fluids are fluids which are intended to be administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury, and there are a number of different types available for use. Many companies manufacture packaged intravenous fluids, as well as products which can be mixed with sterile water to prepare a solution for intravenous administration. Intravenous fluids can be broken into two broad groups. Crystalloids such as saline solutions contain a solution of molecules which can dissolve in water. When crystalloids are administered, they tend to create low osmotic pressure, allowing fluid to move across the blood vessels, and this can be linked with edema. Colloids contain particles which are not soluble in water, and they create high osmotic pressure, attracting fluid into the blood vessels. Blood is an example of a commonly administered intravenous colloid. There are four main ranges of application of highly specialized intravenous infusion solutions: • Treatment of discarded water and electrolyte metabolism, especially in severe cases. • Therapy of acid base in balances. • The volume substitution and volume replacement in surgery of accident victim suffering blood loss. • Paratral nutrition for severally ill and post-operative patients. The global intravenous solutions market size is expected to reach USD 18.9 billion by 2028, the market is expected to expand at a CAGR of 7.9% from 2021 to 2028. The growing incidence rate of chronic diseases such as cancer, increase in the number of premature births, and shortage of I.V. solutions in the U.S. are some of the key factors expected to drive the market. One of the prime areas wherein intravenous (IV) fluids find usage is severe dehydration. Severe dehydration is seen in diseases such as diarrhea, resulting in the depletion of fluids from the body. According to the WHO, in 2017, diarrhea was the second leading cause of death in children under 5 years of age with around 5,25,000 lives lost each year. Intravenous (IV) fluids can play a key role in the treatment and prevention of deaths caused due to the dehydration/fluid loss associated with diarrhea. Other cases where intravenous fluids find application include surgeries and emergency situations.
Plant capacity: IV Fluids (500 ml Size Bottle) 50,000 Bottles per dayPlant & machinery: 3449 Lakhs
Working capital: -T.C.I: Cost of Project: 4089 Lakhs
Return: 20.00%Break even: 41.00%
Add to Inquiry Add to Inquiry Basket

Investment Opportunities in Business of IV Fluids (BFS Technology). Fastest-Growing Industry of Pharmaceuticals.

In hospitals and emergency rooms, intravenous fluids are routinely employed. IV fluids come in a variety of shapes and sizes, and they can be utilised as IV boluses or maintenance fluids. Intravenous (IV) fluids should only be given to patients who cannot meet their needs through oral or enteral routes. Oral fluid intake should be maximised whenever possible, with IV fluid administered primarily to replenish the deficiency. In clinical medicine, intravenous solutions are commonly used to restore and maintain bodily fluids. They are given to people who have lost bodily fluids owing to dehydration or other medical disorders. Intravenous solutions are injected straight into the veins and provide immediate relief to those receiving therapy. About BFS Technology: The container is created, filled, and sealed in one continuous, automated system in blow-fill-seal (BFS) technology, which is a type of advanced aseptic production. The reduction of human participation is a major benefit of this technology, as it lowers the possibility of microbial contamination and foreign particles. Small containers, such as ophthalmic and respiratory medication ampoules, as well as larger capacity containers, such as saline or dextrose solutions, have long employed BFS in liquid pharmaceutical applications. BFS technique has been expanded to include injectables and biologics, such as vaccines and monoclonal antibodies (mAbs). Because of its inherent efficiency and aseptic advantages, the technology is increasingly being used in pharmaceutical packaging, with the US Food and Drug Administration (FDA) now classifying BFS as a "advanced aseptic process," indicating its use as a preferred technology for aseptic packing of liquids and semi-solids. Intravenous fluids are widely utilised in hospitals and clinics. IV fluids are routinely used to rehydrate those who are dehydrated. They can also be used to help people with hypotension or sepsis maintain their blood pressure. IV fluids can also be used as maintenance fluids for people who don't drink enough water during the day. • It's used to supply more fluids and electrolytes to the body when they're needed • It's used to give other pharmaceuticals as a shot • It could be given to you for other reasons. Consult your physician. Intravenous (IV) access is used to provide drugs and fluid replenishment that need to be dispersed throughout the body quickly. The avoidance of first-pass metabolism in the liver is another advantage of IV delivery. The global intravenous solutions market was worth USD 10.7 billion in 2020, and it is predicted to increase at a 7.9% compound annual growth rate (CAGR) from 2021 to 2028. Malnutrition, particularly among the older population as a result of chronic conditions such as cancer, is likely to increase demand for IV treatments in the coming years. One of the most prevalent side effects of cancer is dehydration. Chemotherapy can produce dehydration as a result of side effects such vomiting, diarrhoea, or increased urination, necessitating IV hydration. Over the forecast period, the intravenous solutions market is expected to grow at a CAGR of roughly 4.3 percent. The increase in the prevalence of diseases such as gastrointestinal diseases, neurological diseases, and cancer, where intravenous solutions are the main sources of energy for the patients, is a major factor contributing to the market's growth. Diarrhea is the second largest cause of death in children under the age of five, according to the World Health Organization. Every year, over 1.7 billion instances of infantile diarrhoea sickness are reported worldwide. An increase in the prevalence of chronic and acute disorders, as well as an increase in the elderly population, are driving the global intravenous solutions market. Increased strategic cooperation between manufacturers to improve product portfolios and global presence, expansion in the pharmaceutical business, increased demand for intravenous solutions from developing economies, and increased health-care spending. However, the worldwide intravenous solution market is projected to be restrained by factors such as a strict regulatory environment and expensive fluid maintenance costs. Intravenous medications, nutrients, and fluids have all become commonplace in modern therapy. Key Players • Baxter International Inc • ICU Medical • B. Braun Melsungen Ag • Grifols • Fresenius Kabi USA • Vifor Pharma Management Ltd • JW Life Science • Amanta Healthcare • Axa Parenterals Ltd • Salius Pharma Private Limited.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 5 of 5 | Total 48 projects in this category
« Previous   Page 1 2 3 4 5   »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top